LimaCorporate Brand Guidelines: The Lualdi Family’s 1945 Friulian Implant Maker, Now Enovis

A Friulian implant maker founded in 1945.

LimaCorporate is an orthopaedic implant maker from San Daniele del Friuli, a hill town in Friuli-Venezia Giulia, in north-eastern Italy. According to a September 2023 announcement by its then owner, the Swedish investment firm EQT, the company was founded in 1945 by the Lualdi family and is headquartered in San Daniele. Its business today is joint replacement: EQT described it as a global manufacturer of orthopaedic implants focused on shoulder, knee and hip prostheses.

The same announcement set out what the company had become by 2023. EQT said LimaCorporate’s products were sold in 49 countries, with more than 130,000 implants delivered every year, and that the company operated directly in more than 20 countries. Its range, EQT said, ran from primary and revision implants for the large joints to complete extremities solutions, including fixation, and the company described its own focus as reconstructive and custom-made orthopaedic solutions for surgeons.

Ownership has changed more than once. EQT’s seventh buyout fund, together with co-shareholders, held the company before the 2023 sale. Under that ownership, EQT said, LimaCorporate had grown into one of the leading European orthopaedic companies, expanding its range mainly through in-house development, building up its 3D printing and adding manufacturing capacity as demand grew. The north-east Italian business paper Il Nord Est, reporting the sale on 25 September 2023, noted that EQT had weighed a stock-market listing or a sale to an industrial buyer as early as 2020, before the pandemic paused the process, and that talk of a listing had returned in the months before the deal.

Trabecular Titanium and the SMR shoulder.

The technology most associated with the company in these announcements is Trabecular Titanium, which EQT described as a proprietary, patented titanium structure made by additive manufacturing, or 3D printing. EQT called LimaCorporate’s know-how in additive manufacturing industry-leading, and Enovis, announcing the completed purchase on 3 January 2024, singled out Lima’s 3D printed Trabecular Titanium implants and its comprehensive revision offering for the shoulder. Enovis described Lima as a privately held global orthopaedic company focused on restoring motion through implant solutions, and said its range would strengthen Enovis in what it called the fast-growing extremities market.

Three product families recur in the same releases. The SMR shoulder system is described by EQT as one of the first modular shoulder systems in the world; the Delta family of hip cups and the Physica knee system complete the large-joint range that EQT named.

Lima also took its 3D printing to New York. Il Nord Est reported in 2023 that the company had opened, at the Hospital for Special Surgery in Manhattan, what the paper called the world’s first hub for the 3D printing of orthopaedic prostheses. The paper added that the American market already carried real weight for the San Daniele company.

Production remains rooted in Friuli. In the Italian version of its 2023 announcement, EQT said LimaCorporate’s Italian plants would continue to support the group’s global expansion, and that new investment would speed the completion of a new production site at the San Daniele headquarters. The headline of that Italian release said the San Daniele site would remain the fulcrum of production.

How orthopaedic makers present themselves.

Orthopaedic device makers sell to a narrow, expert audience: surgeons, theatre teams, hospital buyers and the distributors who serve them. Their brand material is shaped by that audience. Product imagery tends to be precise and technical, with implants rendered as clean metallic objects, often lit against dark or neutral backgrounds so that the form of a stem, a plate or a screw reads clearly.

Clinical imagery sits alongside the renders. X-rays, bone models, anatomical cut-aways and diagrams of a joint or a spinal segment show where a device goes and how it is meant to fit. Many makers also photograph surgeons in theatre, in gowns and masks under surgical lights, and show the trays of instruments that accompany an implant system, laid out in rows that suggest order and completeness.

Education is a large part of the picture. Device makers run training courses, cadaver labs and online technique guides, and much of their visual output is instructional: step-by-step surgical technique documents, animations and videos. Congresses matter too. Large meetings such as the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) and the congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) are where new systems are often shown, on stands designed to carry a brand at scale.

Corporate identities in the field are usually restrained: sans-serif wordmarks, a small set of brand colours and a great deal of white space, with the visual drama left to the product and the clinical image. Many brands also sit inside larger groups, so a single name may appear alongside a parent company’s mark. That makes the typeface, the palette and the treatment of imagery the main tools a maker has for being recognised.

Part of Enovis since January 2024.

The sale closed quickly. EQT announced it on 25 September 2023 and expected completion in early 2024; on 3 January 2024 Enovis Corporation, a New York Stock Exchange–listed medical technology company whose release was datelined Wilmington, Delaware, said it had closed the acquisition of LimaCorporate S.p.A. Il Nord Est described Enovis as an American maker of orthopaedic braces and shoe inserts, and Enovis said Lima would strengthen its position in orthopaedic reconstruction with a complementary range of surgical solutions and technologies.

Both sides framed the deal as a fit. In the Italian release, Enovis chief executive Matt Trerotola said the combination would widen the group’s geographic reach and strengthen its position in the world orthopaedic market, while LimaCorporate’s chief executive thanked EQT as a partner that had invested in the business. Il Nord Est put it more vividly: from the following year, the paper wrote, the American flag would fly over the San Daniele plant. In the boilerplate of its 2023 release, LimaCorporate described itself as a global orthopaedic company focused on digital innovation and patient-tailored hardware.

LimaCorporate therefore no longer stands alone. Since January 2024 it has been part of Enovis, and in November 2026 the limacorporate.com address forwarded visitors to the website of Enovis Surgical.

In EQT’s announcement the company’s purpose was summed up in a slogan: helping surgeons restore the “eMotion of Motion” in patients. Its chief executive, Massimo Calafiore, used the same phrase in the Italian release when he looked ahead to the combined group.

For a design guide, LimaCorporate shows how an implant maker can build its identity on a named technology and a handful of product families. Compare Waldemar Link, a family-owned joint-replacement maker in Hamburg, and Zimmer Biomet, a large American joint-replacement group. For this guide we use titanium greys and a deep teal with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep LimaCorporate’s identity on hand — save it to a board in the Made Good inspiration library.